In the south of Tamaulipas It is where the first hospital of the entity specialized in attending to the breast cancer. The authorities are analyzing whether it will be built in Tampico O Altamira.
Velia Patricia Silva Dolphin, delegate of Mexican Institute of Social Security (IMSS), expressed that the place is still being analyzed, since the president of Altamira, Armando Martínez Manríquez, proposed donate three plots of land in various areas; while the mayor of Tampico, Jesús Antonio Nader Nasrallah, offers six hectares for the property.
So the state of Tamaulipas will have a specialized unit in this disease, he stressed that the project is short term, Since while it is being built, a hospital floor will be used to begin providing care.
He stressed that the authorities will visit the area oncological during this week to address important points such as investment in the project, “it will be a state reference center because the breast cancer it affects 3% of the population of women, with which the incidence is very high ”.
LACK OF SPECIALISTS AND ASSORTMENT OF MEDICINES IN TAMAULIPAS
Additionally, it reported that there are specialist deficit What oncologists and ENT, among others, “we have vacancies, but there are no specialists. There are specialists, but they go to private practice, while others are afraid, as is the case of the San Carlos clinic, where there is no Surgeon O gynecologist who wants to take over the management of the hospital ”.
Faced with this situation, they are requesting doctors emergency physicians, internists e intensivists so that they prepare in the Mexico City through a six-week course and add their vocation to be production coordinators of organs and fabrics in the Tamaulipas state.
Subscribe to the digital edition of El Sol de Tampico here
In addition, the delegate reported that Tamaulipas ranks eighth nationally in the assortment of prescriptions, this within the 35 delegations of the country, “we can say that we are complying with the effort of all workers, we are in 93% of the supply.”
Finally he emphasized that where they are having problems is for the assortment of medicines intended for chronic-degenerative diseases.
– .
